Glepaglutide Uses, Dosage, Side Effects and more
Glepaglutide is under investigation in clinical trial NCT00868660 (Healthy Normal Single Ascending Dose and Crohn's Patient Multiple Ascending Dose).
| Attribute | Details |
|---|---|
| Trade Name | Glepaglutide |
| Generic | Glepaglutide |
| Glepaglutide Other Names | Glepaglutide |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
